Of clinical interest, CXCL12/CXCR4 levels are increased in many cancers, including breast cancer, pancreatic cancer, oral squamous cell carcinoma, ovarian cancer, cervical carcinoma, and gastric cancer (37–45). Here, CXCR4 is linked to cancer.